Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Experimental and new investigational drugs for the treatment of uterine fibroids.
Evangelisti G, Ferrero S, Perrone U, Gustavino C, Volpi E, Izzotti A, Barra F. Evangelisti G, et al. Among authors: izzotti a. Expert Opin Investig Drugs. 2024 May;33(5):497-508. doi: 10.1080/13543784.2024.2343786. Epub 2024 Apr 17. Expert Opin Investig Drugs. 2024. PMID: 38618931 Review.
Current Medical Therapy for Adenomyosis: From Bench to Bedside.
Etrusco A, Barra F, Chiantera V, Ferrero S, Bogliolo S, Evangelisti G, Oral E, Pastore M, Izzotti A, Venezia R, Ceccaroni M, Laganà AS. Etrusco A, et al. Among authors: izzotti a. Drugs. 2023 Nov;83(17):1595-1611. doi: 10.1007/s40265-023-01957-7. Epub 2023 Oct 14. Drugs. 2023. PMID: 37837497 Free PMC article. Review.
A review of phase II and III drugs for the treatment and management of endometriosis.
Perrone U, Evangelisti G, Laganà AS, Bogliolo S, Ceccaroni M, Izzotti A, Gustavino C, Ferrero S, Barra F. Perrone U, et al. Among authors: izzotti a. Expert Opin Emerg Drugs. 2023 Dec;28(4):333-351. doi: 10.1080/14728214.2023.2296080. Epub 2023 Dec 26. Expert Opin Emerg Drugs. 2023. PMID: 38099328 Review.
Endometrioma surgery: Hit with your best shot (But know when to stop).
Perrone U, Ferrero S, Gazzo I, Izzotti A, Leone Roberti Maggiore U, Gustavino C, Ceccaroni M, Bogliolo S, Barra F. Perrone U, et al. Among authors: izzotti a. Best Pract Res Clin Obstet Gynaecol. 2024 Sep;96:102528. doi: 10.1016/j.bpobgyn.2024.102528. Epub 2024 Jul 3. Best Pract Res Clin Obstet Gynaecol. 2024. PMID: 38977389 Free article. Review.
MicroRNA and Cancer: A Path to Discovery.
Izzotti A. Izzotti A. Microrna. 2024;13(1):1. doi: 10.2174/221153661301240226102741. Microrna. 2024. PMID: 38841735 No abstract available.
Epigenetic modulation of immune cells: Mechanisms and implications.
Fiordoro S, Rosano C, Pechkova E, Barocci S, Izzotti A. Fiordoro S, et al. Among authors: izzotti a. Adv Biol Regul. 2024 Dec;94:101043. doi: 10.1016/j.jbior.2024.101043. Epub 2024 Aug 10. Adv Biol Regul. 2024. PMID: 39305736 Review.
Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology.
Ben Toumia I, Bachetti T, Chekir-Ghedira L, Profumo A, Ponassi M, Di Domizio A, Izzotti A, Sciacca S, Puglisi C, Forte S, Giuffrida R, Colarossi C, Milardi D, Grasso G, Lanza V, Fiordoro S, Drago G, Tkachenko K, Cardinali B, Romano P, Iervasi E, Vargas GC, Barboro P, Kohnke FH, Rosano C. Ben Toumia I, et al. Among authors: izzotti a. Front Pharmacol. 2024 Jan 3;14:1258108. doi: 10.3389/fphar.2023.1258108. eCollection 2023. Front Pharmacol. 2024. PMID: 38235113 Free PMC article.
275 results